Notably, silencing ALT2 in the liver of obese mice has been reported to diminish alanine-induced hyperglycemia while concurrently elevating serum alanine levels, suggesting a regulatory feedback mechanism pertinent to alanine metabolism in obesity [61]. This evidence concerns the gene GPT2 and obesity disorder.